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Received 26 September 2012; revised 21 November 2012; accepted 18 January 2013AbstractBackground: Although emerging evidence points to benefits from Tai Chi Chuan (TCC) in improving immune system function, its effects on
cellular immune responses remain under-studied. The objective of this study was to evaluate the effects of TCC training on cellular immunity in
non-small cell lung cancer patients.
Methods: A 2-group randomized trial design in which post-surgical, non-small cell lung cancer survivors were randomly assigned to a TCC
training group (n ¼ 16) or a control group (n ¼ 16). The participants in the TCC group completed a 16-week intervention. The main immune
response outcome measures assayed included the ratio of T-helper cells/T-suppressor cells (CD4þ:CD8þ ratio) and complement regulatory
proteins status (CRPs; CD55 and CD59). Using repeated measures ANOVA, the data were analyzed for the participants who completed the study
(n ¼ 27).
Results: At 16 weeks, the TCC participants showed a significantly lower increment in the expression of CD55 ( p < 0.05) as compared to the
control group. No significant between-group differences were found in the CD4þ:CD8þ ratio or CD59 expression. There were also no significant
correlations among the changes in CRPs or T lymphocyte subpopulations, either.
Conclusion: A 16-week TCC intervention caused no alterations in CD4þ:CD8þ ratio, but significantly attenuated CD55 expression among post-
surgical non-small cell lung cancer survivors.
Copyright  2013, Shanghai University of Sport. Production and hosting by Elsevier B.V.
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In many countries, lung cancer is a leading cause of death
with the lowest survival rates and high mortality. In lung cancer,
up to 80% of the cases are associated with non-small cell lung* Corresponding authors.
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Advances in surgical technology and chemotherapy have led to
a significant increase in the long-term survival of non-small cell
lung cancer patients. Studies have shown that in the United
States, approximately 26,000 patients per year will survive
more than 5 years after their initial diagnosis.2 Therefore,
promoting an active lifestyle and improving the quality of life
among non-small cell lung cancer survivors may offer a posi-
tive prognosis, and thereby decrease the recrudescent onco-
genesis risk.
Increasing epidemiological evidence shows that physical
activity is associated with a reduced risk of oncogenesis3e6
and an enhanced quality of life in cancer survivors.7e10 Tai
Chi Chuan (TCC), a traditional Chinese exercise for health
promotion, has also been shown to enhance functional capacityng by Elsevier B.V. Open access under CC BY-NC-ND license.
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vors.11 More recent studies reported that regular TCC exercise
may also help increase the ratio of T-helper/T-suppressor cells
(CD4þ:CD8þ ratio) and mediate Th1/Th2 T-helper cell balance
and reaction toward to Th1, suggesting that TCC training may
elicit healthy immune responses and/or enhance T lymphocyte
anti-neoplastic activity.12,13 TCC, characterized by its slow,
meditative, and moderate-intensity aerobic movements, may
serve as an intervention that offers potential benefit to cancer
survivors by boosting their immune system.14
Based on the current literature in the areas of TCC and
immunology, the purpose of this study was to conduct a pilot
trial aimed at determining whether TCC would result in
changes in the T-helper/T-suppressor (CD4þ:CD8þ) ratio and
membrane expression of the complement regulatory proteins
(CRPs; CD55 and CD59) in non-small cell lung cancer survi-
vors. On the basis of previous findings,12,13 it was hypothesized
that TCC would increase the T-helper/T-suppressor ratio and
decrease the expression of CD55 and CD59. A secondary
hypothesis was that the ratio of T-helper/T-suppressor would be
negatively associated with an attenuated level of expression of
CD55 and CD59.
2. Methods2.1. Study designThe study was a randomized controlled trial with the
participants randomized into either a TCC or a control group.
The participants in the TCC group enrolled in a structured class
three times per week for 16 weeks. The study protocol was
approved by the institution review board in accordance with the
Declaration of Helsinki, and all participants signed informed
consent forms. The clinical study was registered in the Chinese
Clinical Trial Registry (No. ChiCTR-TRC-11001404).2.2. ParticipantsThe subjects were recruited from the Shanghai Lung Cancer
Centre in Shanghai, China. Thirty-two subjects (16 males and
16 females) were enrolled in this study, all of whom were
diagnosed with non-small cell lung cancer (NSCLC) and had
received surgical therapy. Of the total number of enrolled
subjects, 27 completed the study and five dropped out because
of personal reasons (Fig. 1). The inclusion criteria included: (1)
diagnosed with Stage IeIIIB NSCLC as per the guidelines
provided by the American Joint Committee on Cancer and had
received surgical therapy, and (2) had survived the surgery for
more than 2 years and had not received chemotherapy, since
recurrence occurs most with physical activity.15
Participants who were receiving immune therapy were
excluded from this study.2.3. Randomization and maskingUsing a randomized design with computer-generated
random numbers, we assigned the eligible participants in a 1:1ratio to one of the two groups within the strata of their gender.
The randomization codes were kept by an independent
member of the team. The trial was single-blinded with the
assessors blind to the study conditions.2.4. Study conditionsParticipants in the TCC group exercised meditative move-
ments involving the elements of balance, postural alignment,
and mental concentration. The participants learned to perform
24 standard TCC movements, and practicing breathing exer-
cises taught by a senior instructor with 20 years of teaching
experience. Using a polar sport tester (Polar Team2 Pro, Oulu,
Finland), their heart rate (HR) was monitored during TCC
exercise and was set at between 40% and 59% of the
maximum HR.16 The participants in the TCC group underwent
the TCC exercise three times per week; each exercise session
lasted for 60 min, with a 10-min warm-up period and a 10-min
cool down.
Participants in the control group were encouraged not to
modify their daily life activity routine, including diet and
physical activity.2.5. Outcome assessmentPeripheral blood samples from participants who were not
infected with an infectious disease during the past 3 days were
collected at 7:00 am at baseline, and again upon completion of
the 16-week study. The total RBC count, hemoglobin, and
total lymphocyte counts were measured using an automated
hematology analyzer (BC-3000, Shenzhen Mindray Bio-
Medical Electronics CO., Ltd., Shenzhen, China). Flow
cytometry (Beckman Coulter EPICS XL; Beckman Coulter,
Inc., Brea, CA, USA) was used to detect the mean fluores-
cence intensity (MFI) of the CD55/CD59 cells and the
percentages of CD4þ/CD8þ T cell subpopulations. These
analyses were conducted within 24 h after the blood samples
were collected. Using flow cytometry, the CD55/CD59 levels
on the T lymphocytes were evaluated by direct immunofluo-
rescence. Briefly, peripheral blood mononuclear cells (PBMC)
were separated from 100 mL of whole-blood by erythrocyte
lysis using Optilyze C lysing solution (Beckman Coulter), and
then the freshly-isolated PBMCs were washed in stroke-
physiological saline solution. The cells were labeled with
10 mL each of FITC-rat anti-human CD59 or PE-rat anti-
human CD59 (Beckman Coulter) primary antisera, followed
by incubation for 20 min at room temperature. The cells were
washed again after immunostaining, and then analyzed using
an EPICS XL flow cytometer (Beckman Coulter). The
lymphocytes were gated on the basis of forward and side
scatter.17 IgG1 (mouse)-PE monoclonal antibodies (mAbs)
and IgG2a-FITC (mouse) mAbs were used as CD55 and CD59
controls in each assay, respectively. Cells labeled with isotype-
controls were used to set the fluorescence thresholds for
positivity, and thus ＜1% of the cells labeled with isotype-
control antibodies were positive. The MFI were recorded for
lymphocytes expressing CD55 and CD59.17
Fig. 1. Consort flow chart detailing participants recruitment.
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clonal antibodies (Beckman Coulter) were used to evaluate the
levels of the CD3þ/CD4þ/CD8þ T lymphocyte subpopulations,
and Opticlone IG1(mouse)-FITC mAb/IG1(mouse)-PE mAb/
IG1(mouse)-PC5 mAbs served as the isotypic control. Briefly,
20 mL of CD4-FITC/CD8-PE/CD3-PC5 monoclonal antibodies
or 20 mL of Opticlone IG1(mouse)-FITC mAb/IG1(mouse)-PE
mAb/IG1(mouse)-PC5 mAbs were added to the appropriate
tubes, and 100 mL of whole blood was then added into the tubes
and incubated for 15 min at room temperature in the dark, fol-
lowed by erythrocytes lysis. Next, the strained cells were
analyzed using anEPICSXLflow cytometer (BeckmanCoulter).
Lymphocytes were identified on the basis of their forward and
side scatter, and the determination of positivity/negativity of the
immunostained cells were based on the isotypic control. CD3-
PC5 single positive cells were analyzed, and the percentage of
CD3þT lymphocytes was precisely determined. Similarly, CD3-
PC5/CD4-FITC double positive cells or CD3-PC5/CD8-PE
double positive cells were assayed, and the percentages of CD4þ
or CD8þ T lymphocyte subpopulations were simultaneously
determined.2.6. Statistical analysisBaseline demographic descriptors and study outcome
measures were compared between experimental groups using
an analysis of variance for continuous variables, a Chi-square
test for categorical variables, or tests for proportions. Only
data from participants (n ¼ 27) who completed both baseline
and post-intervention assessments were included in the
endpoint analysis. The intervention efficacy was analyzed
using a two-factor (group  time) repeated measures ANOVA
to compare pre- and post-intervention changes in the outcome
measures. The outcome variables analyzed included changesin the percentage of CD4þ and CD8þ T-lymphocytes, the
ratio of T-helper/T-suppressor (CD4þ:CD8þ) cells, and the
expression of CD55 and CD59. A paired t test was used to
assess within-group differences in the outcome variables. The
Pearson rank correlation test was used to evaluate the corre-
lations between the percentage of CD4þ/CD8þ T lymphocyte
subpopulations and the CRPs (CD55 and CD59). All data are
presented as means  SD. All p values are two tailed and
statistical analyses were performed using SPSS, version 17.0
(SPSS Inc., Chicago, IL, USA). Given the exploratory nature
of this preliminary study, no sample size calculations or power
analysis were performed.3. Results
The baseline characteristics of the participants are pre-
sented in Table 1. There were no significant differences in the
demographic details and clinical status between the control
and TCC groups. Intervention group statistics (mean  SD) at
baseline and post-intervention and between-group differences
from pretest to posttest (difference scores) on the study
outcome variables are presented in Table 2.
Although the TCC participants exhibited significant pre-to-
post changes in their CD4þ and CD8þ ( p < 0.05) levels and
more importantly in their CD4þ:CD8þ ratio ( p < 0.05), there
were no between-group differences in these outcome variables.
There was a significant between-group difference in the level of
CD55 lymphocytes ( p ¼ 0.040), indicating that at the end of
the 16-week intervention, the TCC participants exhibited an
attenuated increase from baseline (mean ¼ 1.61) as compared
to the control group (mean ¼ 2.09). However, there were no
significant between group differences in the lymphocyte CD59
levels. Finally, no significant correlations were observed
between changes in the levels of lymphocytes CD55 or CD59
Table 1
Anthropometric and physiologic characteristics of the participants.
Characteristics Control Tai Chi Chuan
Gender (male/female)a 8/6 7/6
Age (years)b 59.27  7.68 63.07  7.89
Body mass index (kg/m2)b 22.12  83 21.87  74




Stage I/IIeIIIa 9/5 7/6
RBC (1012)b 4.10  0.43 4.07  0.20
Hemoglobin (g/L)b 134.77  12.50 135.27  13.95
Lymphocytes (109)b 1.85  0.50 1.78  0.48
a No significant differences were observed between the groups using the
Chi-square test.
b Data are presented as means  SD. No significant differences were
observed between the groups using an unpaired t test.
Table 3
Correlations between changes in lymphocyte CD55:CD59 levels and CD4þ/
CD8þ T lymphocyte subpopulations.
Variables Controla Tai Chi Chuana
DCD55 DCD59 DCD55 DCD59
DCD4 (%) 0.14 (0.65) 0.02 (0.95) 0.11 (0.72) 0.50 (0.07)
DCD8 (%) 0.07 (0.82) 0.25 (0.69) 0.28 (0.32) 0.07 (0.80)
DCD4þ:CD8þ
ratio
0.13 (0.67) 0.29 (0.33) 0.04 (0.90) 0.19 (0.52)
a Correlation data are presented as r values ( p).
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subpopulations and CD4þ:CD8þ ratio in either of the two study
groups (Table 3).4. Discussion
In this randomized pilot study, we evaluated the effects of
a 16-week TCC intervention on the lymphocytes CRPs (CD55
and CD59), the ratio of helper to suppressor T lymphocytes in
post-surgical non-small cell lung cancer survivors. The major
finding is that a 16-week TCC intervention significantly
attenuated the increase in lymphocyte CD55 levels, which
has been shown to negatively impact T cell immunity.18,19
However, there were no significant changes in the ratio of
helper to suppressor T cells after the TCC intervention, and no
significant correlations were observed amongst the changes in
the lymphocyte CD55 and T lymphocyte subpopulations.
Research using animal models has shown the importance of
decay accelerating factors such as CD55 in modulating T cell
responses.20 Thus, lymphocytes expressing decreased CD55
levels may enhance T cell immunity. However, it remains
largely unclear how exercise, such as TCC, can influence
lymphocytes expressing CD55 and CD59. One possible
molecular mechanism might be complement activation and
chronic inflammation. Research from the use of animal-basedTable 2
CD4þ/CD8þ T lymphocyte subpopulations and CRPs (CD55 and CD59) levels on
Variables Controla Tai C
t ¼ 0 t ¼ 16 weeks Differences t ¼ 0
CD4 (%) 41.35  10.17 40.72  11.47 0.62  2.75 35.62
CD8 (%) 24.13  8.52 20.63  7.20 3.50  4.38 24.53
CD4þ:CD8þ ratio 2.06  0.30 2.40  1.52 0.34  0.69 1.62
CD55 (MFI) 1.61  0.09 3.70  0.34* 2.09  0.34 1.63
CD59 (MFI) 4.74  0.79 3.61  0.65* 1.13  0.93 4.75
*p < 0.05, paired t test differences within groups over time.
# p < 0.05, represents unpaired t test mean differences between groups.
Abbreviation: MFI ¼ mean fluorescence intensity.
a Data are presented as means  SD.
b Repeated measures ANOVA analysis.models suggested that CD55 may be expressed by neurons
during chronic nervous inflammation associated complement
activation,21 and previous studies also suggested that regular
aerobic exercise could selectively down-regulate complement
fragments and induce anti-inflammatory effects.22e24 It is
therefore possible that TCC exercise, when used as a form of
complementary and alternative medicine, may share the
benefits produced by aerobic exercise, thus resulting in
reduced chronic inflammation and complement activation
which could be linked to a down-regulation of CD55.
The results from the current study showed that TCC exer-
cise significantly attenuated the lymphocytes CD55 increase;
however, no significant correlations were observed for any
changes in the lymphocyte subpopulations. It is well-known
that CD55 regulates T cell immunity via its influence on
lymphocytes producing INF-g, which may cause a more
polarized th1 cell response.18,19 Therefore, the ratio of helper/
suppressor T cells may be not specific to changes in
lymphocyte CD55 levels. In addition, a previous study showed
that lymphocytes expressing low levels of CD55 and CD59
immediately increased their expression post-exercise after
intensive and downhill treadmill running at 80% maximal
oxygen uptake (VO2max), but showed no changes after
moderate treadmill running at 60%VO2max.
25 Therefore, one
may speculate that lymphocytes expressing low levels of
CD55 and CD59 were altered due to lymphocyte redistribution
during acute exercise, but do not represent lymphocyte CRPs
varying at the cellular level. However, our results were
congruent with those reported by Wang et al.26 in that a 4-
week diet and moderate exercise program induced a lympho-
cyte CD55 level decrease in overweight adolescents. Theselymphocytes at t ¼ 0 and t ¼ 16 weeks.
hi Chuana Time-by-group interactionb
p value
t ¼ 16 weeks Differences
 9.83 32.97  8.27* 2.65  4.18 0.442
 8.95 19.92  8.62* 4.61  3.01 0.620
 0.78 1.88  0.80* 0.25  0.30 0.673
 0.08 3.24  0.72* 1.61  0.72# 0.040
 0.71 3.25  0.22* 1.50  0.67 0.467
108 Y.-J. Zhang et al.results collectively suggest that changes in the lymphocyte
CRPs (CD55 and CD59) may be related to the intensity and
duration of the exercise regimen applied. Furthermore,
evidence suggests that long-term, moderate exercise may be
beneficial to overall health. Therefore, future studies should
investigate whether long-term exercise would result in
a meaningful change in lymphocytes expressing CD55, and
how these changes may be related to immune health.
In conclusion, the current study demonstrated that a 16-week
TCC intervention showed no effect on changes in the
CD4þ:CD8þ ratio, but TCC training significantly attenuated
the levels of lymphocytes expressing CD55 in post-surgical,
non-small cell lung cancer survivors. These results, although
promising, await future corroboration at a larger scale.
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